FDA grants Theradaptive Breakthrough Medical Device designation
Theradaptive's regenerative implants are best-in-class and are designed to permit precise tissue regeneration for a variety of tissue types and clinical indications
Theradaptive's regenerative implants are best-in-class and are designed to permit precise tissue regeneration for a variety of tissue types and clinical indications
Premas Biotech is the developer of the technology for the Covid-19 vaccine and a shareholder in Oravax Medical
It is used for the treatment of advanced colorectal and gastric cancer
The nutraceutical sector is on the cusp of exponential growth and Covid-19 has accelerated the pace of its applications. Dr R.B Smarta, CMD, Interlink, shares his perspective on the growth opportunities and challenges for the sector
Nelarabine is in a class of medications called antimetabolites
It is anticipated to be safe and efficacious by targeting the receptor-binding domain (RBD) of the new coronavirus
Six-months follow-up of prevention trial showed 83% reduced risk of symptomatic Covid-19, with no severe disease or deaths
Branded and unbranded versions of the first-ever interchangeable biosimilar in the U.S. provide more affordable options for the millions of Americans living with diabetes
The cream has an estimated market size of US $ 28 million for twelve months ending Jun 2021 according to IQVIA
Launching in 2022, its availability will be expanded to the global market
Subscribe To Our Newsletter & Stay Updated